Finding 570053 (2024-016)

Material Weakness
Requirement
B
Questioned Costs
$1
Year
2024
Accepted
2025-07-02
Audit: 361368
Auditor: Dwc

AI Summary

  • Core Issue: Solvista Health overcharged fringe benefits to a federal grant by using a rate of 31.15%, exceeding the agreed maximum of 30.15% and not reflecting actual costs of 25%.
  • Impacted Requirements: Compliance with 2 CFR 200.430 was violated, leading to an overstatement of fringe benefits and indirect costs.
  • Recommended Follow-Up: Implement a robust internal control system for reviewing fringe benefit rates and regularly reconcile budgeted versus actual costs to ensure compliance.

Finding Text

Criteria or Specific Requirement: In accordance with 2 CFR 200.430, fringe benefits should be allocated based on an approved indirect cost rate agreement (if applicable) or on actual costs when no approved rate exists. If a predetermined or negotiated rate has been established, it must be applied consistently and accurately across all programs. Condition: Solvista Health utilized a fringe benefit allocation rate of 31.15% when allocating fringe benefit expenditures to the Certified Community Behavioral Health Clinic Expansion Grant. However, the maximum agreed-upon fringe benefit rate submitted to the grantor was 30.15%. Additionally, it was noted that the actual fringe benefit expenditures incurred by the organization during the period were estimated at 25%. Context: Fringe benefits should have been charged at a rate consistent with Solvista Health’s actual fringe benefit expenditures incurred and should not have exceeded the maximum allowed rate. These errors resulted in an overstatement of fringe benefits and related indirect costs applied to the grant. Questioned Costs: $18,307 consisting of an accounting error in applying a fringe benefit rate higher than the maximum rate, in addition to applying the maximum fringe benefit rate rather than actual fringe benefit expenditures incurred. Cause: These errors were due to clerical errors in applying a fringe benefit rate higher than the agreed upon maximum fringe benefit rate, in addition to applying a maximum fringe benefit rate to the program rather than actual fringe benefit expenditures incurred by Solvista Health. Solvista Health lacks a properly designed and implemented system of internal control with regards to review and approval of costs submitted for reimbursement, Effect: Solvista Health improperly overstated fringe benefit expenditures allocated to the federal program during the performance period. This resulted in an excess reimbursement of program expenditures and questioned costs. Identification as a Repeat Finding: Not a repeat finding. Recommendation: We recommend that Solvista Health design and implement a system of internal controls which includes a review process to ensure accurate use of approved fringe benefit rates in all federal reporting. Additionally, management should reconcile budgeted and actual fringe benefit costs regularly to ensure continued compliance.

Corrective Action Plan

Solvista Health management agrees with the auditor’s finding. In conjunction with the shared services agreement, the Group will design and implement a system of internal controls which includes a review process to ensure accurate use of approved fringe benefit rates in all federal reporting. The Group will reconcile budgeted and actual fringe benefit costs regularly to ensure continued compliance.

Categories

Questioned Costs Allowable Costs / Cost Principles Cash Management Period of Performance Reporting

Other Findings in this Audit

  • 570052 2024-015
    Material Weakness
  • 570054 2024-018
    Significant Deficiency
  • 570055 2024-019
    Significant Deficiency
  • 570056 2024-019
    Significant Deficiency
  • 570057 2024-019
    Significant Deficiency
  • 570058 2024-020
    Significant Deficiency
  • 570059 2024-020
    Significant Deficiency
  • 570060 2024-020
    Significant Deficiency
  • 570061 2024-021
    Significant Deficiency
  • 570062 2024-022
    Significant Deficiency
  • 570063 2024-022
    Significant Deficiency
  • 570064 2024-022
    Significant Deficiency
  • 570065 2024-022
    Significant Deficiency
  • 570066 2024-023
    Significant Deficiency
  • 570067 2024-023
    Significant Deficiency
  • 570068 2024-023
    Significant Deficiency
  • 570069 2024-023
    Significant Deficiency
  • 570070 2024-024
    Significant Deficiency
  • 570071 2024-024
    Significant Deficiency
  • 570072 2024-025
    Significant Deficiency
  • 570073 2024-025
    Significant Deficiency
  • 570074 2024-026
    Significant Deficiency
  • 570075 2024-027
    Significant Deficiency
  • 570076 2024-027
    Significant Deficiency
  • 570077 2024-028
    Significant Deficiency
  • 570078 2024-029
    Significant Deficiency
  • 570079 2024-029
    Significant Deficiency
  • 570080 2024-029
    Significant Deficiency
  • 570081 2024-014
    Material Weakness
  • 570082 2024-014
    Material Weakness
  • 570083 2024-014
    Material Weakness
  • 570084 2024-014
    Material Weakness
  • 570085 2024-014
    Material Weakness
  • 570086 2024-014
    Material Weakness
  • 570087 2024-014
    Material Weakness
  • 570088 2024-014
    Material Weakness
  • 570089 2024-014
    Material Weakness
  • 570090 2024-014
    Material Weakness
  • 570091 2024-014
    Material Weakness
  • 570092 2024-014
    Material Weakness
  • 570093 2024-017
    Significant Deficiency
  • 570094 2024-017
    Significant Deficiency
  • 570095 2024-029
    Significant Deficiency
  • 1146494 2024-015
    Material Weakness
  • 1146495 2024-016
    Material Weakness
  • 1146496 2024-018
    Significant Deficiency
  • 1146497 2024-019
    Significant Deficiency
  • 1146498 2024-019
    Significant Deficiency
  • 1146499 2024-019
    Significant Deficiency
  • 1146500 2024-020
    Significant Deficiency
  • 1146501 2024-020
    Significant Deficiency
  • 1146502 2024-020
    Significant Deficiency
  • 1146503 2024-021
    Significant Deficiency
  • 1146504 2024-022
    Significant Deficiency
  • 1146505 2024-022
    Significant Deficiency
  • 1146506 2024-022
    Significant Deficiency
  • 1146507 2024-022
    Significant Deficiency
  • 1146508 2024-023
    Significant Deficiency
  • 1146509 2024-023
    Significant Deficiency
  • 1146510 2024-023
    Significant Deficiency
  • 1146511 2024-023
    Significant Deficiency
  • 1146512 2024-024
    Significant Deficiency
  • 1146513 2024-024
    Significant Deficiency
  • 1146514 2024-025
    Significant Deficiency
  • 1146515 2024-025
    Significant Deficiency
  • 1146516 2024-026
    Significant Deficiency
  • 1146517 2024-027
    Significant Deficiency
  • 1146518 2024-027
    Significant Deficiency
  • 1146519 2024-028
    Significant Deficiency
  • 1146520 2024-029
    Significant Deficiency
  • 1146521 2024-029
    Significant Deficiency
  • 1146522 2024-029
    Significant Deficiency
  • 1146523 2024-014
    Material Weakness
  • 1146524 2024-014
    Material Weakness
  • 1146525 2024-014
    Material Weakness
  • 1146526 2024-014
    Material Weakness
  • 1146527 2024-014
    Material Weakness
  • 1146528 2024-014
    Material Weakness
  • 1146529 2024-014
    Material Weakness
  • 1146530 2024-014
    Material Weakness
  • 1146531 2024-014
    Material Weakness
  • 1146532 2024-014
    Material Weakness
  • 1146533 2024-014
    Material Weakness
  • 1146534 2024-014
    Material Weakness
  • 1146535 2024-017
    Significant Deficiency
  • 1146536 2024-017
    Significant Deficiency
  • 1146537 2024-029
    Significant Deficiency

Programs in Audit

ALN Program Name Expenditures
93.696 Certified Community Behavioral Health Clinic Expansion Grants $381,902
93.778 Medical Assistance Program $349,300
93.575 Child Care and Development Block Grant $334,148
21.027 Coronavirus State and Local Fiscal Recovery Funds $219,142
93.665 Emergency Grants to Address Mental and Substance Use Disorders During Covid-19 $124,108
16.745 Criminal and Juvenile Justice and Mental Health Collaboration Program $114,870
93.870 Maternal, Infant and Early Childhood Home Visiting Grant $75,205
93.958 Block Grants for Community Mental Health Services $20,000
93.069 Public Health Emergency Preparedness $10,300